Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 4
2023 2
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study.
Conway A, Valerio H, Alavi M, Silk D, Treloar C, Hajarizadeh B, Marshall AD, Martinello M, Milat A, Dunlop A, Murray C, Prain B, Henderson C, Amin J, Read P, Marks P, Degenhardt L, Hayllar J, Reid D, Gorton C, Lam T, Christmass M, Wade A, Montebello M, Dore GJ, Grebely J; ETHOS Engage Study Group. Conway A, et al. Viruses. 2022 Jul 16;14(7):1555. doi: 10.3390/v14071555. Viruses. 2022. PMID: 35891535 Free PMC article.
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.
Valerio H, Alavi M, Conway A, Silk D, Treloar C, Martinello M, Milat A, Dunlop A, Murray C, Henderson C, Amin J, Read P, Marks P, Degenhardt L, Stevens A, Prain B, Hayllar J, Reid D, Montebello M, Wade A, Christmass M, Cock V, Dore GJ, Grebely J; ETHOS Engage Study Group. Valerio H, et al. Int J Drug Policy. 2022 Jul;105:103706. doi: 10.1016/j.drugpo.2022.103706. Epub 2022 May 6. Int J Drug Policy. 2022. PMID: 35533635
Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study.
Valerio H, Marshall AD, Conway A, Treloar C, Carter L, Martinello M, Henderson C, Amin J, Read P, Silk D, Degenhardt L, Prain B, Alavi M, Dore GJ, Grebely J; ETHOS Engage Study Group. Valerio H, et al. Int J Drug Policy. 2024 May;127:104394. doi: 10.1016/j.drugpo.2024.104394. Epub 2024 Apr 11. Int J Drug Policy. 2024. PMID: 38608357 Free article.
Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia: The ETHOS engage study.
Hobday S, Valerio H, Combo T, Monaghan R, Scott C, Silk D, Murray C, Read P, Henderson C, Degenhardt L, Treloar C, Dore GJ, Grebely J, Martinello M; ETHOS Engage Study Group. Hobday S, et al. Drug Alcohol Rev. 2023 Nov;42(7):1617-1632. doi: 10.1111/dar.13723. Epub 2023 Aug 9. Drug Alcohol Rev. 2023. PMID: 37556376 Free PMC article.
Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study.
Valerio H, Conway A, Alavi M, Treloar C, Silk D, Murray C, Henderson C, Amin J, Read P, Degenhardt L, Christmass M, Montebello M, Dore GJ, Grebely J; ETHOS Engage Study Group. Valerio H, et al. Int J Drug Policy. 2022 Dec;110:103876. doi: 10.1016/j.drugpo.2022.103876. Epub 2022 Oct 12. Int J Drug Policy. 2022. PMID: 36240657
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.
Conway A, Valerio H, Peacock A, Degenhardt L, Hayllar J, Harrod ME, Henderson C, Read P, Gilliver R, Christmass M, Dunlop A, Montebello M, Whitton G, Reid D, Lam T, Alavi M, Silk D, Marshall AD, Treloar C, Dore GJ, Grebely J; ETHOS Engage Study Group. Conway A, et al. Int J Drug Policy. 2021 Oct;96:103421. doi: 10.1016/j.drugpo.2021.103421. Epub 2021 Aug 25. Int J Drug Policy. 2021. PMID: 34452808
Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study.
Wheeler A, Valerio H, Cunningham EB, Martinello M, Barocas JA, Colledge-Frisby S, Treloar C, Amin J, Henderson C, Read P, Matthews GV, Dunlop AJ, Gorton C, Hayllar J, Alavi M, Murray C, Marks P, Silk D, Degenhardt L, Dore GJ, Grebely J; ETHOS Engage Study Group. Wheeler A, et al. Drug Alcohol Depend. 2022 Aug 1;237:109543. doi: 10.1016/j.drugalcdep.2022.109543. Epub 2022 Jun 26. Drug Alcohol Depend. 2022. PMID: 35772249
A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage Study.
Marshall AD, Conway A, Cunningham EB, Valerio H, Silk D, Alavi M, Tillakeratne S, Wade A, Lam T, Zohrab K, Dunlop A, Connelly C, Cock V, Burns C, Henderson C, Christmass M, Dore GJ, Grebely J; ETHOS Engage Study Group. Marshall AD, et al. Viruses. 2024 Nov 12;16(11):1763. doi: 10.3390/v16111763. Viruses. 2024. PMID: 39599877 Free PMC article. Clinical Trial.
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs.
Broady TR, Valerio H, Alavi M, Wheeler A, Silk D, Martinello M, Conway A, Milat A, Dunlop A, Murray C, Henderson C, Amin J, Read P, Marks P, Degenhardt L, Stevens A, Prain B, Hayllar J, Reid D, Montebello M, Wade A, Christmass M, Cock V, Dore GJ, Treloar C, Grebely J; ETHOS Engage Study Group. Broady TR, et al. Int J Drug Policy. 2024 Jun;128:104468. doi: 10.1016/j.drugpo.2024.104468. Epub 2024 May 24. Int J Drug Policy. 2024. PMID: 38795465 Free article.
11 results